Results 311 to 320 of about 305,984 (384)

Early diagnostic value of novel biomarkers for breast cancer therapy‐related cardiac dysfunction

open access: yesESC Heart Failure, EarlyView.
Our meta‐analysis revealed significant post‐treatment increases in GDF‐15, CRP, MPO, and PLGF levels (Gal‐3 unchanged) among breast cancer patients. Only elevated MPO levels were significantly associated with an increased risk of cancer therapy‐related cardiac dysfunction (CTRCD).
Zhengwei Wang   +4 more
wiley   +1 more source

Left ventricle myocardial remodeling following septal myectomy in patients with hypertrophic obstructive cardiomyopathy

open access: gold
Guanyu Lu   +12 more
openalex   +1 more source

Ventricular Approach for Functional Mitral Regurgitation in Cardiomyopathy

open access: hybrid, 2013
Kenji Minakata   +6 more
openalex   +2 more sources

Early in‐hospital treatment of acute heart failure. Part 2 of the international expert opinion series on AHF management

open access: yesESC Heart Failure, EarlyView.
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu   +22 more
wiley   +1 more source

Letter to the Editor: CRISPR-based gene editing for cardiac protection in Barth syndrome. [PDF]

open access: yesAnn Med Surg (Lond)
Abedin ZU   +4 more
europepmc   +1 more source

Digital implementation strategy to increase SGLT2 inhibitor uptake in heart failure: Study design of EMAIL‐HF

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The EMAIL‐HF trial aims to evaluate whether a digital guideline implementation strategy can increase and accelerate initiation of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and results EMAIL‐HF is a pragmatic, registry‐based, randomized controlled trial including patients with a ...
Mariam Elmegaard   +21 more
wiley   +1 more source

Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials

open access: yesESC Heart Failure, EarlyView.
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz   +5 more
wiley   +1 more source

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

Cardiac rehabilitation and health‐related quality of life in preserved ejection fraction heart failure: A meta‐analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The study aims to evaluate the effects of exercise‐based cardiac rehabilitation (ExCR) on the health‐related quality of life (HRQoL) in people with heart failure preserved ejection fraction (HFpEF). Methods This study is a systematic review and meta‐analysis.
Chenyao Ding, Yawen Gao, Rod S. Taylor
wiley   +1 more source

Home - About - Disclaimer - Privacy